Dune Medical Devices

About:

Dune Medical Devices is engaged in the development and commercialization of intraoperative, real-time, cancer detection devices.

Website: http://www.dunemedical.com

Twitter/X: MarginProbe

Top Investors: Apax Partners, EASME - EU Executive Agency for SMEs, The Kraft Group, Evidity Health Capital, Boston MedTech Advisors

Description:

Dune Medical Devices was founded in 2002 to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the ability to detect cancer in real time, this technology holds promise for a broad range of diagnostic and therapeutic applications. Surgeons who fight cancer on a daily basis must always contend with the lingering question, “Did I get it all?” It forces those who tackle breast cancer to consistently balance the imperative towards aggressive treatment with the desire to conserve tissue. A critical leveler in that struggle may be MarginProbe™ from Dune Medical. The MarginProbe™ System delivers real-time cancer detection in the OR for a simple and immediate assessment of cancer on the margin of excised tissue. In a randomized study of 300 breast cancer patients in Israel, the reoperation rate was reduced by 56% vs. standard of care when the MarginProbe System was employed.